Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Curidium is a drug discovery and development company focused on identifying targeted medicines to treat patients more effectively. Curidium has developed a novel and proprietary technology, Homomatrix®, to untangle the underlying mechanisms of human diseases. Curidium’s technology identifies different patient subpopulations each having a distinct disease mechanism. This enables the generation of new diagnostic tools and medicines designed for a subgroup of patients and potentially offering improved safety and effectiveness. Curidium is initially applying its core technology to diseases of the Central Nervous System. Curidium listed on the AIM of the London Stock Exchange on 6 July 2006 and trades under the symbol CUR. Recent News: 15 Dec 2006 ( www.curidium.com )
Curidium Limited
Hamilton House Mabledon Place
London WC1H 9BB
United Kingdom
Tel: +44 20 7554 8790